.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have achieved a breakthrough in liver-targeted mRNA delivery by developing a novel immune-modulating nanodrug. This innovation addresses a significant hurdle in genetic medicine. Currently, inflammation often hampers the success of mRNA-based therapies. Specifically, inflammatory states trigger a self-defensive response in hepatocytes. This mechanism downregulates global protein synthesis to block potential viral threats. However, it also significantly reduces the efficiency of therapeutic mRNA delivered via lipid nanoparticles (LNPs).
Furthermore, the team introduced a telodendrimer (TD) nanodrug (ND) to modulate the immune environment. They tested this technology in both human and mouse immune cells. Additionally, the researchers evaluated its effects on primary human hepatocytes (PHH). The results were impressive. The TD ND successfully inhibited endotoxin-induced inflammation. Consequently, this led to improved cell proliferation and significantly higher mRNA uptake in human monocytes and liver cells.
Moreover, the findings demonstrated that TD ND is superior to conventional steroid drugs. While steroids are common, they can sometimes impair liver recovery. In contrast, the TD ND sustained liver function in mice while rebooting the efficacy of liver-targeted mRNA delivery. Therefore, this adjuvant therapy offers a promising path for treating inflammatory liver diseases.
Inflammation acts as a biological barrier. It triggers a cellular defense that reduces mRNA expression, which prevents therapeutic genes from being translated into functional proteins.
The TD nanodrug acts as an immune modulator. It inhibits the inflammatory response that normally blocks mRNA expression, thereby enhancing the overall delivery efficiency and liver function.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new telodendrimer nanodrug improves liver-targeted mRNA delivery by suppressing inflammation and outperforming traditional steroids in preclinical studies...
7 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
